Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A Receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists

Molecular and Cellular Proteomics

Volumn 13, Issue 5, 2014, Pages 1273-1285

  Karaki, Samah ^a,b   Becamel, Carine ^a,b   Murat, Samy ^a,b   Cour, Clotilde Mannoury La ^c   Millan, Mark J ^c   Prezeau, Laurent ^a,b   Bockaert, Joel ^a,b   Marin, Philippe ^a,b   Vandermoere, Franck ^a,b  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b UNIV MONTPELLIER   (France)

^c INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMPHETAMINE DERIVATIVE; LISURIDE; SEROTONIN 2A RECEPTOR; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; PSYCHEDELIC AGENT; SERINE; SEROTONIN 2 AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; EMBRYO; HEK293 CELL LINE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MOUSE; NERVE CELL; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PHOSPHORYLATION; PROCEDURES;

AMPHETAMINES; ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HALLUCINOGENS; HEK293 CELLS; HUMANS; LISURIDE; MICE; NEURONS; PHOSPHORYLATION; PREFRONTAL CORTEX; PROTEOMICS; RECEPTOR, SEROTONIN, 5-HT2A; SERINE; SEROTONIN 5-HT2 RECEPTOR AGONISTS; SIGNAL TRANSDUCTION;

EID: 84899714796     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.036558     Document Type: Article

References (46)

1. Meltzer, H. Y., Massey, B. W., and Horiguchi, M. (2012) Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia. Curr. Pharm. Biotechnol. 13, 1572-1586
2. Roth, B. L., Berry, S. A., Kroeze, W. K., Willins, D. L., and Kristiansen, K. (1998) Serotonin 5-HT2A receptors: Molecular biology and mechanisms of regulation. Crit. Rev. Neurobiol. 12, 319-338
3. Gray, J. A., and Roth, B. L. (2007) Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr. Bull. 33, 1100-1119
4. Aghajanian, G. K., and Marek, G. J. (1999) Serotonin and hallucinogens. Neuropsychopharmacology 21, 16S-23S
5. Nichols, D. E. (2004) Hallucinogens. Pharmacol. Ther. 101, 131-181
6. Gonzalez-Maeso, J., and Sealfon, S. C. (2009) Psychedelics and schizophrenia. Trends Neurosci. 32, 225-232
7. Gonzalez-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., Sealfon, S. C., and Gingrich, J. A. (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53, 439-452
8. Gonzalez-Maeso, J., Yuen, T., Ebersole, B. J., Wurmbach, E., Lira, A., Zhou, M., Weisstaub, N., Hen, R., Gingrich, J. A., and Sealfon, S. C. (2003) Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J. Neurosci. 23, 8836-8843
9. Gonzalez-Maeso, J., and Sealfon, S. C. (2009) Agonist-trafficking and hallucinogens. Curr. Med. Chem. 16, 1017-1027
10. Becamel, C., Gavarini, S., Chanrion, B., Alonso, G., Galeotti, N., Dumuis, A., Bockaert, J., and Marin, P. (2004) The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins. J. Biol. Chem. 279, 20257-20266
11. Malinow, R., Hayashi, Y., Maletic-Savatic, M., Zaman, S. H., Poncer, J. C., Shi, S. H., Esteban, J. A., Osten, P., and Seidenman, K. (2010) Introduction of green fluorescent protein (GFP) into hippocampal neurons through viral infection. Cold Spring Harb. Protoc. 2010, pdb prot5406
12. Dubois, F., Vandermoere, F., Gernez, A. l., Murphy, J., Toth, R., Chen, S., Geraghty, K. M., Morrice, N. A., and MacKintosh, C. (2009) Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling. Mol. Cell. Proteomics 8, 2487-2499
13. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
14. Weiss, S., Pin, J. P., Sebben, M., Kemp, D. E., Sladeczek, F., Gabrion, J., and Bockaert, J. (1986) Synaptogenesis of cultured striatal neurons in serum-free medium: A morphological and biochemical study. Proc. Natl. Acad. Sci. U.S.A. 83, 2238-2242
15. McNulty, D. E., and Annan, R. S. (2008) Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Mol. Cell. Proteomics 7, 971-980
16. Cox, J. R., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteomewide protein quantification. Nat Biotechnol. 26, 1367-1372
17. Martin, D. M., Nett, I. R., Vandermoere, F., Barber, J. D., Morrice, N. A., and Ferguson, M. A. (2010) Prophossi: Automating expert validation of phosphopeptide-spectrum matches from tandem mass spectrometry. Bioinformatics 26, 2153-2159
18. Chanrion, B., Mannoury la Cour, C., Gavarini, S., Seimandi, M., Vincent, L., Pujol, J. F., Bockaert, J., Marin, P., and Millan, M. J. (2008) Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: Differential modulation of cell surface expression and signal transduction. Mol. Pharmacol. 73, 748-757
19. Miner, L. A., Backstrom, J. R., Sanders-Bush, E., and Sesack, S. R. (2003) Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 116, 107-117
20. Songyang, Z., Blechner, S., Hoagland, N., Hoekstra, M. F., Piwnica-Worms, H., and Cantley, L. C. (1994) Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr. Biol. 4, 973-982
21. Dinkel, H., Chica, C., Via, A., Gould, C. M., Jensen, L. J., Gibson, T. J., and Diella, F. (2011) Phospho.ELM: A database of phosphorylation sites-update 2011. Nucleic Acids Res. 39, D261-267
22. Xue, Y., Ren, J., Gao, X., Jin, C., Wen, L., and Yao, X. (2008) GPS 2.0, a Tool to Predict Kinase-specific Phosphorylation Sites in Hierarchy. Mol. Cell. Proteomics 7, 1598-1608
23. Sullivan, J. P., Connor, J. R., Shearer, B. G., and Burch, R. M. (1991) 2,6-Diamino-N-([1-oxotridecyl)-2-piperidinyl]methyl)hexanamide (NPC 15437): A selective inhibitor of protein kinase C. Agents Actions 34, 142-144
24. Heerding, D. A., Rhodes, N., Leber, J. D., Clark, T. J., Keenan, R. M., Lafrance, L. V., Li, M., Safonov, I. G., Takata, D. T., Venslavsky, J. W., Yamashita, D. S., Choudhry, A. E., Copeland, R. A., Lai, Z., Schaber, M. D., Tummino, P. J., Strum, S. L., Wood, E. R., Duckett, D. R., Eberwein, D., Knick, V. B., Lansing, T. J., McConnell, R. T., Zhang, S., Minthorn, E. A., Concha, N. O., Warren, G. L., and Kumar, R. (2008) Identification of 4-(2-(4-amino-1,2,5- oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c] pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase. J. Med. Chem. 51, 5663-5679
25. Smith, J. A., Poteet-Smith, C. E., Xu, Y., Errington, T. M., Hecht, S. M., and Lannigan, D. A. (2005) Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res. 65, 1027-1034
26. Strachan, R. T., Sheffler, D. J., Willard, B., Kinter, M., Kiselar, J. G., and Roth, B. L. (2009) Ribosomal S6 Kinase 2 Directly Phosphorylates the 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptor, Thereby Modulating 5-HT2A Signaling. J. Biol. Chem. 284, 5557-5573
27. Raote, I., Bhattacharyya, S., and Panicker, M. M. (2013) Functional selectivity in serotonin receptor 2A (5-HT2A) endocytosis, recycling, and phosphorylation. Mol. Pharmacol. 83, 42-50
28. Bhattacharyya, S., Puri, S., Miledi, R., and Panicker, M. M. (2002) Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms. Proc. Natl. Acad. Sci. U.S.A. 99, 14470-14475
29. Berg, K. A., Stout, B. D., Maayani, S., and Clarke, W. P. (2001) Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation. J. Pharmacol. Exp. Ther. 299, 593-602
30. Gelber, E. I., Kroeze, W. K., Willins, D. L., Gray, J. A., Sinar, C. A., Hyde, E. G., Gurevich, V., Benovic, J., and Roth, B. L. (1999) Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor: The third intracellular loop is alpha-helical and binds purified arrestins. J. Neurochem. 72, 2206-2214
31. Kenakin, T. (2007) Collateral efficacy in drug discovery: Taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol. Sci. 28, 407-415
32. Galandrin, S., Oligny-Longpre, G., and Bouvier, M. (2007) The evasive nature of drug efficacy: Implications for drug discovery. Trends Pharmacol. Sci. 28, 423-430
33. Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., Miller, K. J., Spedding, M., and Mailman, R. B. (2007) Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 320, 1-13
34. Reiter, E., Ahn, S., Shukla, A. K., and Lefkowitz, R. J. (2012) Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu. Rev. Pharmacol. Toxicol. 52, 179-197
35. Nobles, K. N., Xiao, K., Ahn, S., Shukla, A. K., Lam, C. M., Rajagopal, S., Strachan, R. T., Huang, T. Y., Bressler, E. A., Hara, M. R., Shenoy, S. K., Gygi, S. P., and Lefkowitz, R. J. (2011) Distinct phosphorylation sites on the beta(2)-adrenergic receptor establish a barcode that encodes differential functions of beta-arrestin. Sci. Signal. 4, ra51
36. Butcher, A. J., Prihandoko, R., Kong, K. C., McWilliams, P., Edwards, J. M., Bottrill, A., Mistry, S., and Tobin, A. B. (2011) Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code. J. Biol. Chem. 286, 11506-11518
37. Busillo, J. M., Armando, S., Sengupta, R., Meucci, O., Bouvier, M., and Benovic, J. L. (2010) Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J. Biol. Chem. 285, 7805-7817
38. Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., and Lefkowitz, R. J. (2007) A unique mechanism of beta-blocker action: Carvedilol stimulates beta-arrestin signaling. Proc. Natl. Acad. Sci. U.S.A. 104, 16657-16662
39. Trinidad, J. C., Barkan, D. T., Gulledge, B. F., Thalhammer, A., Sali, A., Schoepfer, R., and Burlingame, A. L. (2012) Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse. Mol. Cell. Proteomics. 11, 215-229
40. Strachan, R. T., Allen, J. A., Sheffler, D. J., and Roth, B. L. (2010) p90 Ribosomal S6 kinase 2, a novel GPCR kinase, is required for growth factor-mediated attenuation of GPCR signaling. Biochemistry 49, 2657-2671
41. Gray, J. A., Compton-Toth, B. A., and Roth, B. L. (2003) Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization. Biochemistry 42, 10853-10862
42. Fiorella, D., Rabin, R. A., and Winter, J. C. (1995) Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives. Psychopharmacology (Berl) 121, 357-363
43. Bhatnagar, A., Willins, D. L., Gray, J. A., Woods, J., Benovic, J. L., and Roth, B. L. (2001) The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis. J. Biol. Chem. 276, 8269-8277
44. Schmid, C. L., Raehal, K. M., and Bohn, L. M. (2008) Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc. Natl. Acad. Sci. U.S.A. 105, 1079-1084
45. Gonzalez-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., Lopez-Gimenez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., Gingrich, J. A., Filizola, M., Meana, J. J., and Sealfon, S. C. (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 452, 93-97
46. Moreno, J. L., Muguruza, C., Umali, A., Mortillo, S., Holloway, T., Pilar-Cuellar, F., Mocci, G., Seto, J., Callado, L. F., Neve, R. L., Milligan, G., Sealfon, S. C., Lopez-Gimenez, J. F., Meana, J. J., Benson, D. L., and Gonzalez-Maeso, J. (2012) Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A.mGlu2) receptor heteromerization and its psychoactive behavioral function. J. Biol. Chem. 287, 44301-44319